The Haematological Oncology CSG is one of the largest and most complex CSGs, with 7 disease-specific Subgroups, one Working Group and an overall trial portfolio of more than 100 studies. In addition to contributing to the design of individual study proposals, the CSG plays a crucial cross-cutting role in setting expectations, sharing best practice and addressing common challenges.
The CSG also provides a framework for co-ordinating and driving forward research in areas that transcend individual disease areas, such as supportive care/late effects, stem cell transplantation/cellular therapy and TYA. During the last year, the CSG has built on its performance in previous years in terms of trial development, with a high level of success in obtaining funding for new studies.
Links with other relevant parties including other CSGs, industry partners, international collaborative groups and LCRN Subspecialty Leads have been further strengthened, and the CSG has continued to engage with local clinical research teams and national patient groups via numerous disease-specific educational events. The CSG has also had a major impact on clinical practice through the delivery of several pivotal studies and through the contribution of CSG/Subgroup members to numerous NICE appraisals.
To book a place please contact firstname.lastname@example.org.